Search results
Showing 1 to 7 of 7 results for ursodeoxycholic acid
Obeticholic acid for treating primary biliary cholangitis (TA443)
Evidence-based recommendations on obeticholic acid (Ocaliva) for treating primary biliary cholangitis in adults.
Seladelpar for previously treated primary biliary cholangitis ID6429
In development [GID-TA11540] Expected publication date: 10 September 2025
This guideline covers diagnosing and managing cystic fibrosis. It specifies how to monitor the condition and manage the symptoms to improve quality of life. There are also detailed recommendations on treating the most common infections in people with cystic fibrosis.
Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis?
Liver disease:- Should all children with meconium ileus receive ursodeoxycholic acid from diagnosis? Any explanatory notes(if...
Odevixibat for treating progressive familial intrahepatic cholestasis (HST17)
Evidence-based recommendations on odevixibat (Bylvay) for treating progressive familial intrahepatic cholestasis in people 6 months and older.
Elafibranor for previously treated primary biliary cholangitis (TA1016)
Evidence-based recommendations on elafibranor (Iqirvo) for previously treated primary biliary cholangitis in adults.
CG155/2 | What is the clinical and cost effectiveness of omega-3 fatty acids in the treatment of children and young people considered...